Raras
Buscar doenças, sintomas, genes...
Neuropatia óptica hereditária
ORPHA:98671CID-11 · 9C40.8DOENÇA RARA

Atrofia óptica ou atrofia ótica é a perda de algumas ou da maioria das fibras do nervo óptico. Na medicina, atrofia significa normalmente "encolhido mas capaz de recrescer ", assim alguns discutem que atrofia óptica como um termo patológico está um pouco errado, usando assim Neuropatia óptica.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por perda visual progressiva (escotoma), ptose bilateral e fraqueza muscular. Pode apresentar miopatia mitocondrial, neuropatia axonal motora e sensorial, com alterações na transmissão neuromuscular e na retina. Associada a mutações em genes como FERMT3 e genes mitocondriais.

Pesquisas ativas
10 ensaios
41 total registrados no ClinicalTrials.gov
Publicações científicas
2.123 artigos
Último publicado: 2026 Jan-Dec
Medicamentos
1 registrados
CYCLOSPORINE

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
CYCLOSPORINE
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
48 sintomas
👁️
Olhos
47 sintomas
🦴
Ossos e articulações
35 sintomas
💪
Músculos
17 sintomas
❤️
Coração
13 sintomas
😀
Face
12 sintomas

+ 123 sintomas em outras categorias

Características mais comuns

Escotoma
Ptose bilateral
EMG: sinais de desnervação crônica
Miopatia mitocondrial
Fraqueza muscular da cintura escapular/pélvica
Neuropatia axonal motora
359sintomas
Sem dados (359)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 359 características clínicas mais associadas, ordenadas por frequência.

EscotomaScotoma
Ptose bilateralBilateral ptosis
EMG: sinais de desnervação crônicaEMG: chronic denervation signs
Miopatia mitocondrialMitochondrial myopathy
Fraqueza muscular da cintura escapular/pélvicaLimb-girdle muscle weakness

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.123PubMed
Últimos 10 anos200publicações
Pico2025123 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

29 genes identificados com associação a esta condição.

FERMT3Fermitin family homolog 3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Plays a central role in cell adhesion in hematopoietic cells (PubMed:19234463, PubMed:26359933). Acts by activating the integrin beta-1-3 (ITGB1, ITGB2 and ITGB3) (By similarity). Required for integrin-mediated platelet adhesion and leukocyte adhesion to endothelial cells (PubMed:19234460). Required for activation of integrin beta-2 (ITGB2) in polymorphonuclear granulocytes (PMNs) (By similarity) Isoform 2 may act as a repressor of NF-kappa-B and apoptosis

LOCALIZAÇÃO

Cell projection, podosome

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Leukocyte adhesion deficiency 3

A disorder characterized by recurrent bacterial infections without pus formation, leukocytosis and major bleeding disorders.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
258.2 TPM
Linfócitos
220.1 TPM
Baço
175.3 TPM
Pulmão
75.3 TPM
Intestino delgado
36.9 TPM
OUTRAS DOENÇAS (1)
leukocyte adhesion deficiency 3
HGNC:23151UniProt:Q86UX7
MT-CO1Cytochrome c oxidase subunit 1Candidate gene tested inDesconhecido
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (6)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (6)
mitochondrial diseaseMELAS syndromemitochondrial complex IV deficiency, nuclear-typemitochondrial non-syndromic sensorineural hearing loss
HGNC:7419UniProt:P00395
MT-ND5NADH-ubiquinone oxidoreductase chain 5Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:15250827). Essential for the catalytic activity and assembly of complex I (PubMed:15250827)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseaseMELAS syndromematernally-inherited Leigh syndromeMERRF syndrome
HGNC:7461UniProt:P03915
MT-CO3Cytochrome c oxidase subunit 3Candidate gene tested inDesconhecido
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (5)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseasemitochondrial complex IV deficiency, nuclear-typeMELAS syndromehereditary recurrent myoglobinuria
HGNC:7422UniProt:P00414
MT-ND4LNADH-ubiquinone oxidoreductase chain 4LCandidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:28844695). Part of the enzyme membrane arm which is embedded in the lipid bilayer and involved in proton translocation (PubMed:28844695)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Mitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (1)
Leber hereditary optic neuropathy
HGNC:7460UniProt:P03901
MT-ATP6ATP synthase F(0) complex subunit aCandidate gene tested inDesconhecido
FUNÇÃO

Subunit a, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationFormation of ATP by chemiosmotic couplingCristae formationMitochondrial protein degradation
MECANISMO DE DOENÇA

Neuropathy, ataxia, and retinitis pigmentosa

A syndrome characterized by variable combination of developmental delay, psychomotor retardation, hearing loss, optic atrophy and retinitis pigmentosa, dementia, seizures, ataxia, proximal neurogenic muscle weakness, and sensory neuropathy.

OUTRAS DOENÇAS (8)
mitochondrial diseasematernally-inherited Leigh syndromefamilial infantile bilateral striatal necrosismitochondrial proton-transporting ATP synthase complex deficiency
HGNC:7414UniProt:P00846
MT-CYBCytochrome bCandidate gene tested inDesconhecido
FUNÇÃO

Component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex) that is part of the mitochondrial respiratory chain. The b-c1 complex mediates electron transfer from ubiquinol to cytochrome c. Contributes to the generation of a proton gradient across the mitochondrial membrane that is then used for ATP synthesis

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex III assemblyMitochondrial translation termination
OUTRAS DOENÇAS (4)
mitochondrial diseaseLeber hereditary optic neuropathyhistiocytoid cardiomyopathymitochondrial complex III deficiency
HGNC:7427UniProt:P00156
DNAJC30DnaJ homolog subfamily C member 30, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Mitochondrial protein enriched in neurons that acts as a regulator of mitochondrial respiration (By similarity). Associates with the ATP synthase complex and facilitates ATP synthesis (By similarity). May be a chaperone protein involved in the turnover of the subunits of mitochondrial complex I N-module. It facilitates the degradation of N-module subunits damaged by oxidative stress, and contributes to complex I functional efficiency (PubMed:33465056)

LOCALIZAÇÃO

Mitochondrion inner membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
27.4 TPM
Pituitária
18.9 TPM
Glândula adrenal
18.8 TPM
Tireoide
18.3 TPM
Brain Frontal Cortex BA9
15.8 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
Leber-like hereditary optic neuropathy, autosomal recessive 1Williams syndromeLeber hereditary optic neuropathy
HGNC:16410UniProt:Q96LL9
MT-ND6NADH-ubiquinone oxidoreductase chain 6Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14595656, PubMed:8644732). Essential for the catalytic activity and assembly of complex I (PubMed:14595656, PubMed:8644732)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseaseLeber plus diseasematernally-inherited Leigh syndromeMELAS syndrome
HGNC:7462UniProt:P03923
NDUFS2NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential for the catalytic activity of complex I (PubMed:22036843, PubMed:30922174). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature w

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 6

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN6 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
154.5 TPM
Ovário
130.0 TPM
Cérebro - Hemisfério cerebelar
124.7 TPM
Coração - Ventrículo esquerdo
120.8 TPM
Cerebelo
120.6 TPM
OUTRAS DOENÇAS (4)
mitochondrial complex I deficiency, nuclear type 6Leber-like hereditary optic neuropathy, autosomal recessive 2mitochondrial complex I deficiencyLeber hereditary optic neuropathy
HGNC:7708UniProt:O75306
MT-ND1NADH-ubiquinone oxidoreductase chain 1Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:1959619). Essential for the catalytic activity and assembly of complex I (PubMed:1959619, PubMed:26929434)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseaseMELAS syndromemitochondrial complex I deficiencymaternally-inherited Leigh syndrome
HGNC:7455UniProt:P03886
MT-ND4NADH-ubiquinone oxidoreductase chain 4Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:15250827, PubMed:8344246, PubMed:8644732). Essential for the catalytic activity and assembly of complex I (PubMed:15250827, PubMed:8344246, PubMed:8644732)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (6)
mitochondrial diseasematernally-inherited Leigh syndromeMELAS syndromeLeber plus disease
HGNC:7459UniProt:P03905
MT-ND2NADH-ubiquinone oxidoreductase chain 2Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:16996290). Essential for the catalytic activity and assembly of complex I (PubMed:16996290)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (4)
mitochondrial diseaseLeber hereditary optic neuropathymaternally-inherited Leigh syndromemitochondrial complex I deficiency
HGNC:7456UniProt:P03891
SLC4A2Anion exchange protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Sodium-independent anion exchanger which mediates the electroneutral exchange of chloride for bicarbonate ions across the cell membrane (PubMed:15184086, PubMed:34668226). Plays an important role in osteoclast differentiation and function (PubMed:34668226). Regulates bone resorption and calpain-dependent actin cytoskeleton organization in osteoclasts via anion exchange-dependent control of pH (By similarity). Essential for intracellular pH regulation in CD8(+) T-cells upon CD3 stimulation, modul

LOCALIZAÇÃO

Apical cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (1)
Bicarbonate transporters
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 9

A form of osteopetrosis, a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB9 is characterized by increased bone density and bone fragility, as well as renal failure.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
57.0 TPM
Estômago
56.9 TPM
Útero
55.4 TPM
Cervix Ectocervix
50.9 TPM
Cólon sigmoide
49.9 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
osteopetrosis, autosomal recessive 9
HGNC:HGNC:11028UniProt:P04920
PLEKHM1Pleckstrin homology domain-containing family M member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a multivalent adapter protein that regulates Rab7-dependent and HOPS complex-dependent fusion events in the endolysosomal system and couples autophagic and the endocytic trafficking pathways. Acts as a dual effector of RAB7A and ARL8B that simultaneously binds these GTPases, bringing about clustering and fusion of late endosomes and lysosomes (PubMed:25498145, PubMed:28325809). Required for late stages of endolysosomal maturation, facilitating both endocytosis-mediated degradation of gro

LOCALIZAÇÃO

Autolysosome membraneEndosome membraneLate endosome membraneLysosome membrane

MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 6

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
41.0 TPM
Cerebelo
25.4 TPM
Cérebro - Hemisfério cerebelar
22.4 TPM
Skin Sun Exposed Lower leg
21.8 TPM
Vagina
21.3 TPM
OUTRAS DOENÇAS (2)
osteopetrosis, autosomal dominant 3autosomal recessive osteopetrosis 6
HGNC:29017UniProt:Q9Y4G2
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
OPA3Optic atrophy 3 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May play some role in mitochondrial processes

LOCALIZAÇÃO

Mitochondrion

MECANISMO DE DOENÇA

3-methylglutaconic aciduria 3

An autosomal recessive metabolic disorder that causes a neuro-ophthalmologic syndrome consisting of early-onset bilateral optic atrophy, spasticity, extrapyramidal dysfunction and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and 3-methylglutaric acid is increased. MGCA3 can be distinguished from MGCA1 by the absence of increase of 3-hydroxyisovaleric acid levels.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
11.2 TPM
Pituitária
8.7 TPM
Fibroblastos
7.7 TPM
Glândula adrenal
7.7 TPM
Baço
7.2 TPM
OUTRAS DOENÇAS (2)
optic atrophy 33-methylglutaconic aciduria type 3
HGNC:8142UniProt:Q9H6K4
TNFRSF11ATumor necrosis factor receptor superfamily member 11ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis (PubMed:9878548). Its interaction with EEIG1 promotes osteoclastogenesis via facilitating the transcription of NFATC1 and activation of PLCG2 (By similarity). Involved in the regulation of interactions between T-cells and dendritic cells (By similarity)

LOCALIZAÇÃO

Cell membraneMembrane raft

VIAS BIOLÓGICAS (2)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Familial expansile osteolysis

Rare autosomal dominant bone disorder characterized by focal areas of increased bone remodeling. The osteolytic lesions develop usually in the long bones during early adulthood. FEO is often associated with early-onset deafness and loss of dentition.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula salivar
10.6 TPM
Pituitária
9.9 TPM
Cólon transverso
8.4 TPM
Intestino delgado
7.9 TPM
Skin Sun Exposed Lower leg
2.8 TPM
OUTRAS DOENÇAS (6)
familial expansile osteolysisautosomal recessive osteopetrosis 7adult-onset myasthenia gravisdysosteosclerosis
HGNC:11908UniProt:Q9Y6Q6
OPA1Dynamin-like GTPase OPA1, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function (PubMed:16778770, PubMed:17709429, PubMed:20185555, PubMed:24616225, PubMed:28628083, PubMed:28746876, PubMed:31922487, PubMed:32228866, PubMed:32567732, PubMed:33130824, PubMed:33237841, PubMed:37612504, PubMed:37612506). Exists in two forms: the transmembrane, long form (Dynamin-like GTPas

LOCALIZAÇÃO

Mitochondrion inner membraneMitochondrion intermembrane space

VIAS BIOLÓGICAS (2)
Regulation of ApoptosisMitochondrial protein degradation
MECANISMO DE DOENÇA

Optic atrophy 1

A condition that features progressive visual loss in association with optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. OPA1 is characterized by an insidious onset of visual impairment in early childhood with moderate to severe loss of visual acuity, temporal optic disk pallor, color vision deficits, and centrocecal scotoma of variable density.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.7 TPM
Fibroblastos
33.7 TPM
Cérebro - Hemisfério cerebelar
29.1 TPM
Brain Frontal Cortex BA9
28.8 TPM
Artéria tibial
26.8 TPM
OUTRAS DOENÇAS (6)
optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathyautosomal dominant optic atrophy, classic formBehr syndromemitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)
HGNC:8140UniProt:O60313
OSTM1Osteopetrosis-associated transmembrane protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for osteoclast and melanocyte maturation and function

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 5

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB5 patients manifest primary central nervous system involvement in addition to the classical stigmata of severe bone sclerosis, growth failure, anemia, thrombocytopenia and visual impairment with optic atrophy.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
42.5 TPM
Aorta
32.9 TPM
Artéria coronária
32.7 TPM
Esôfago - Muscular
26.2 TPM
Cólon sigmoide
25.0 TPM
OUTRAS DOENÇAS (2)
autosomal recessive osteopetrosis 5infantile osteopetrosis with neuroaxonal dysplasia
HGNC:21652UniProt:Q86WC4
CA2Carbonic anhydrase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the reversible hydration of carbon dioxide (PubMed:11327835, PubMed:11802772, PubMed:11831900, PubMed:12056894, PubMed:12171926, PubMed:1336460, PubMed:14736236, PubMed:15300855, PubMed:15453828, PubMed:15667203, PubMed:15865431, PubMed:16106378, PubMed:16214338, PubMed:16290146, PubMed:16686544, PubMed:16759856, PubMed:16807956, PubMed:17127057, PubMed:17251017, PubMed:17314045, PubMed:17330962, PubMed:17346964, PubMed:17540563, PubMed:17588751, PubMed:17705204, PubMed:18024029, PubMe

LOCALIZAÇÃO

CytoplasmCell membrane

VIAS BIOLÓGICAS (4)
Erythrocytes take up carbon dioxide and release oxygenErythrocytes take up oxygen and release carbon dioxideReversible hydration of carbon dioxideDevelopmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 3

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB3 is associated with renal tubular acidosis, cerebral calcification (marble brain disease) and in some cases with intellectual disability.

OUTRAS DOENÇAS (1)
autosomal recessive osteopetrosis 3
HGNC:1373UniProt:P00918
TNFSF11Tumor necrosis factor ligand superfamily member 11Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy (PubMed:22664871). Induces osteoclastogenesis by

LOCALIZAÇÃO

Cell membraneCytoplasmSecreted

VIAS BIOLÓGICAS (4)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathwayTNFs bind their physiological receptorsTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 2

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB2 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
14.7 TPM
Testículo
1.7 TPM
Intestino delgado
0.6 TPM
Fígado
0.3 TPM
Baço
0.2 TPM
OUTRAS DOENÇAS (2)
autosomal recessive osteopetrosis 2autosomal recessive osteopetrosis
HGNC:11926UniProt:O14788
DNM1LDynamin-1-like proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions in mitochondrial and peroxisomal division (PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17460227, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:19342591, PubMed:19411255, PubMed:19638400, PubMed:23283981, PubMed:23530241, PubMed:23921378, PubMed:26992161, PubMed:27145208, PubMed:27145933, PubMed:27301544, PubMed:27328748, PubMed:29478834, PubMed:32439975, PubMed:32484300, PubMed:9570752, PubMed:9786947). Mediates membrane fission through oligomerization into me

LOCALIZAÇÃO

Cytoplasm, cytosolGolgi apparatusEndomembrane systemMitochondrion outer membranePeroxisomeMembrane, clathrin-coated pitCytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane

VIAS BIOLÓGICAS (1)
Apoptotic execution phase
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
97.7 TPM
Cerebelo
77.7 TPM
Brain Frontal Cortex BA9
61.7 TPM
Linfócitos
57.7 TPM
Fibroblastos
52.2 TPM
OUTRAS DOENÇAS (3)
optic atrophy 5encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1autosomal dominant optic atrophy, classic form
HGNC:2973UniProt:O00429
SLC38A8Solute carrier family 38 member 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Electrogenic sodium-dependent amino acid transporter with a preference for L-glutamine, L-alanine, L-histidine, L-aspartate and L-arginine. May facilitate glutamine uptake in both excitatory and inhibitory neurons. The transport mechanism and stoichiometry remain to be elucidated

LOCALIZAÇÃO

MembraneCytoplasm, cell cortexCell projection, axon

MECANISMO DE DOENÇA

Foveal hypoplasia 2

An isolated form of foveal hypoplasia, a developmental defect of the eye defined as the lack of foveal depression with continuity of all neurosensory retinal layers in the presumed foveal area. Clinical features include absence of foveal pit on optical coherence tomography, absence of foveal hyperpigmentation, absence of foveal avascularity, absence of foveal and macular reflexes, decreased visual acuity, and nystagmus. Optic nerve misrouting and anterior segment dysgenesis are observed in some FVH2 patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cérebro - Amígdala
1.7 TPM
Pituitária
1.4 TPM
Brain Frontal Cortex BA9
1.2 TPM
Córtex cerebral
1.1 TPM
Testículo
0.8 TPM
OUTRAS DOENÇAS (1)
foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome
HGNC:32434UniProt:A6NNN8
ALPK1Alpha-protein kinase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine/threonine-protein kinase that detects bacterial pathogen-associated molecular pattern metabolites (PAMPs) and initiates an innate immune response, a critical step for pathogen elimination and engagement of adaptive immunity (PubMed:28222186, PubMed:28877472, PubMed:30111836). Specifically recognizes and binds ADP-D-glycero-beta-D-manno-heptose (ADP-Heptose), a potent PAMP present in all Gram-negative and some Gram-positive bacteria (PubMed:30111836). ADP-Heptose-binding stimulates its kin

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Alpha-protein kinase 1 signaling pathwayTAK1-dependent IKK and NF-kappa-B activation
MECANISMO DE DOENÇA

Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome

An autosomal dominant disorder characterized by decreased vision associated with optic nerve edema, evident in childhood. Low-grade ocular inflammation is common in affected individuals. Later in childhood or the second decade of life, patients have increasing visual impairment, abnormal cone function and loss of rod function. By the third decade of life, visual acuity ranges from counting fingers to no light perception. Patients also show anhidrosis, splenomegaly, mild pancytopenia, and most experience headaches that may be migraine-like in nature.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome
HGNC:20917UniProt:Q96QP1
CLCN7H(+)/Cl(-) exchange transporter 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Slowly voltage-gated channel mediating the exchange of chloride ions against protons (PubMed:18449189, PubMed:21527911). Functions as antiporter and contributes to the acidification of the lysosome lumen and may be involved in maintaining lysosomal pH (PubMed:18449189, PubMed:21527911, PubMed:31155284). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (By similarity). The presence of conserved gating

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 4

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.

VIAS REACTOME (1)
OUTRAS DOENÇAS (5)
autosomal dominant osteopetrosis 2autosomal recessive osteopetrosis 4hypopigmentation, organomegaly, and delayed myelination and developmentautosomal recessive osteopetrosis
HGNC:2025UniProt:P51798
TCIRG1V-type proton ATPase 116 kDa subunit a 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (By similarity). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). Seems to be directly involved in T-cell a

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transport
MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 1

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
473.7 TPM
Baço
357.4 TPM
Cervix Endocervix
257.4 TPM
Pulmão
249.1 TPM
Cervix Ectocervix
190.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive osteopetrosis 1autosomal dominant severe congenital neutropeniadysosteosclerosisautosomal recessive osteopetrosis
HGNC:11647UniProt:Q13488
PAX6Paired box protein Pax-6Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Acts as a transcriptional repressor of NFATC1-mediated gene expression (By s

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)Regulation of gene expression in beta cellsActivation of anterior HOX genes in hindbrain development during early embryogenesisFormation of the anterior neural plateSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
MECANISMO DE DOENÇA

Aniridia 1

A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.8 TPM
Cerebelo
36.9 TPM
Córtex cerebral
3.5 TPM
Brain Caudate basal ganglia
3.4 TPM
Brain Anterior cingulate cortex BA24
3.3 TPM
OUTRAS DOENÇAS (17)
coloboma, ocular, autosomal dominantisolated optic nerve hypoplasiaautosomal dominant keratitisfoveal hypoplasia 1
HGNC:8620UniProt:P26367
SNX10Sorting nexin-10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Probable phosphoinositide-binding protein involved in protein sorting and membrane trafficking in endosomes. Plays a role in cilium biogenesis through regulation of the transport and the localization of proteins to the cilium. Required for the localization to the cilium of V-ATPase subunit ATP6V1D and ATP6V0D1, and RAB8A. Involved in osteoclast differentiation and therefore bone resorption

LOCALIZAÇÃO

CytoplasmEndosome membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosome

MECANISMO DE DOENÇA

Osteopetrosis, autosomal recessive 8

A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB8 is clinically characterized by dense bones with no distinction between outer and inner plates, due to extensive encroachment of cortical bone into the medullary space, increased head circumference, broad open fontanelle, frontal bossing, and hepatosplenomegaly. Osteoclasts number is low and their bone resorptive capacity is impaired.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
60.8 TPM
Hipotálamo
40.1 TPM
Brain Anterior cingulate cortex BA24
38.5 TPM
Linfócitos
33.5 TPM
Cérebro - Hemisfério cerebelar
27.4 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
autosomal recessive osteopetrosis 8autosomal recessive osteopetrosis
HGNC:14974UniProt:Q9Y5X0

Medicamentos e terapias

CYCLOSPORINEPhase 2

Mecanismo: Cyclophilin A modulator

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

138 variantes patogênicas registradas no ClinVar.

🧬 FERMT3: NM_031471.6(FERMT3):c.1295_1296insACTGCGGTGCCAGGATGTGAGTGAGATCTA (p.Tyr432Ter) ()
🧬 FERMT3: NM_031471.6(FERMT3):c.224del (p.Gln75fs) ()
🧬 FERMT3: NM_031471.6(FERMT3):c.1462del (p.His488fs) ()
🧬 FERMT3: NM_031471.6(FERMT3):c.786+258G>T ()
🧬 FERMT3: NM_031471.6(FERMT3):c.-14-9T>A ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 15 variantes classificadas pelo ClinVar.

11
4
Patogênica (73.3%)
VUS (26.7%)
VARIANTES MAIS SIGNIFICATIVAS
DMP1-AS1: NM_014208.3(DSPP):c.3267_3401del (p.Asn1092_Ser1136del) [Conflicting classifications of pathogenicity]
DNAJC30: NM_032317.3(DNAJC30):c.227ACC[1] (p.His77del) [Pathogenic]
DNAJC30: NM_032317.3(DNAJC30):c.610G>T (p.Glu204Ter) [Pathogenic]
DNAJC30: NM_032317.3(DNAJC30):c.130_131del (p.Ser44fs) [Pathogenic]
NDUFS2: NM_001377299.1(NDUFS2):c.923A>G (p.Tyr308Cys) [Pathogenic]

Vias biológicas (Reactome)

39 vias biológicas associadas aos genes desta condição.

Platelet degranulation Mitochondrial translation termination TP53 Regulates Metabolic Genes Respiratory electron transport Cytoprotection by HMOX1 Mitochondrial protein degradation Complex IV assembly Complex I biogenesis Formation of ATP by chemiosmotic coupling Cristae formation Complex III assembly Bicarbonate transporters Ion homeostasis Ion transport by P-type ATPases Potential therapeutics for SARS TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Regulation of Apoptosis Stimuli-sensing channels Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Reversible hydration of carbon dioxide Developmental Lineage of Pancreatic Ductal Cells TNFs bind their physiological receptors Transcriptional and post-translational regulation of MITF-M expression and activity Apoptotic execution phase TAK1-dependent IKK and NF-kappa-B activation Alpha-protein kinase 1 signaling pathway ROS and RNS production in phagocytes Neutrophil degranulation Insulin receptor recycling Transferrin endocytosis and recycling Amino acids regulate mTORC1 Ion channel transport Regulation of gene expression in beta cells Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Activation of anterior HOX genes in hindbrain development during early embryogenesis Formation of the anterior neural plate

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 36
2Fase 26
1Fase 12
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Neuropatia óptica hereditária

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

41 ensaios clínicos encontrados, 10 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.009 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.009

#1

Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.

Science advances2026 Feb 20

Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy caused by OPA1 variants, leading to retinal ganglion cell (RGC) degeneration and vision loss. The mechanisms behind RGC vulnerability to mitochondrial dysfunction remain unclear. We developed a patient-specific Opa1V291D/+ knock-in mouse model to investigate mitochondrial dysfunction and retinal metabolism in ADOA. We observed that Opa1V291D/+ mice exhibited anatomical and functional RGC abnormalities recapitulating the ADOA phenotypes. Reduced optic atrophy 1 (OPA1) protein levels were noted in Opa1V291D/+ mice, accompanied by decreased protein stability. Moreover, mitochondrial function was compromised, as indicated by reduced Complex I activity, increased oxidative stress, and diminished adenosine triphosphate production in the retinas of Opa1V291D/+ mice. Spatial metabolomics revealed energy deficits in the inner retina and heightened glycolysis in the outer retina. Immunostaining showed decreased expression of glycolytic proteins in the ganglion cell layer. Single-nucleus RNA sequencing disclosed significant down-regulation of energy-production genes in RGCs, while other retinal cell types remained unaffected. These findings emphasize the specific vulnerability of RGCs to bioenergetic crises, connecting disrupted energy homeostasis to their degeneration. By increasing the nicotinamide adenine dinucleotide (NAD+)/reduced form of NAD+ (NADH) redox ratio through the overexpression of mitochondrial-targeted Lactobacillus brevis NADH oxidase (MitoLbNOX) in RGCs, we demonstrated improved RGC function and survival through enhanced energy metabolism and reduced oxidative stress. These findings confirm that disrupted energy metabolism leads to RGC degeneration and emphasize the enhancement of the NAD+/NADH redox ratio as a promising treatment strategy to protect RGCs from degeneration in ADOA.

#2

Pharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.

Investigative ophthalmology & visual science2026 Feb 02

The Vglut2-Cre;ndufs4loxP/loxP mouse strain with retinal ganglion cell (RGC)-specific mitochondrial complex I dysfunction develops severe RGC degeneration by postnatal day 90 (P90), with accompanying retinal mononuclear phagocyte (MNP) accumulation. We have reported that continuous exposure to hypoxia partially rescues RGC death in these mice, with minimal effect on MNP abundance. We hypothesized that pharmacological depletion of MNPs with the colony-stimulating factor-1 receptor inhibitor pexidartinib would enhance RGC neuroprotection by hypoxia. Iba1+ retinal MNP depletion was assessed in C57Bl/6J mice fed control or pexidartinib-infused chow beginning at P25. Subsequently, Vglut2-Cre;ndufs4loxP/loxP mice and control littermates were raised under normoxia or hypoxia and fed control or pexidartinib chow from P25 to P90. The neuroprotective effect of pexidartinib and hypoxia alone and in combination was assessed by quantifying RGC soma and axon survival in retinal flat mounts and optic nerve cross-sections. Pexidartinib completely depleted retinal MNPs within 1 week of treatment. Untreated Vglut2-Cre;ndufs4loxP/loxP mice exhibited the expected approximately 50% reduction of RGC soma and axon survival at P90 (P < 0.0001 for both). Hypoxia or pexidartinib monotherapy each reduced RGC degeneration by more than one-half, whereas their combination resulted in complete RGC neuroprotection (P < 0.01 for all 3 treatments). Normal myelination patterns were restored in mice receiving dual therapy. Pexidartinib effectively depletes retinal MNPs and is neuroprotective in the setting of severe RGC mitochondrial dysfunction. This therapeutic effect is additive to that of hypoxia. Combating retinal neuro-inflammation may therefore be a useful adjunct therapy in mitochondrial optic neuropathies like Leber hereditary optic neuropathy (LHON).

#3

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Jan 02

Leber's hereditary optic neuropathy (LHON) is a mitochondrial disorder typically presenting with subacute, painless, bilateral vision loss in young individuals. While often recognizable, atypical presentations can complicate diagnosis. Notably, optic nerve lesions on MRI are uncommon in LHON and are typically associated with inflammatory optic neuropathies, increasing the risk of misdiagnosis. We retrospectively analyzed four patients who initially presented with suspected optic neuritis but were later diagnosed with LHON. Demographic, genetic, clinical, and multimodal data were retrieved from medical records. The series included two adolescent males, a 51-year-old man, and a 52-year-old woman. All experienced subacute, bilateral vision loss and were later found to carry pathogenic LHON mutations. However, their initial presentations were misleading. The two adult patients presented beyond the typical age of onset; one was initially diagnosed with glaucoma due to increased intraocular pressure, while the other had a history of Fahr's syndrome. One adolescent reported ocular pain with eye movements and showed a relative afferent pupillary defect, mimicking optic neuritis. Two patients lacked typical fundoscopic findings suggestive of LHON. MRI findings further complicated the diagnosis: all patients showed T2-FLAIR hyperintensities of the optic nerves with contrast enhancement, and in three cases abnormalities extended posteriorly to the chiasm and optic tracts on follow-up MRI. MRI abnormalities involving the optic pathway do not exclude LHON and may be present in atypical cases. LHON should be considered in all patients presenting with bilateral subacute visual loss, even when clinical or imaging features suggest alternative diagnoses.

#4

Modifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.

European journal of human genetics : EJHG2026 Feb

Leber's hereditary optic neuropathy (LHON) is a debilitating mitochondrial disease characterised by bilateral painless vision loss. Despite being the most prevalent mitochondrial disorder, the precise pathophysiological mechanisms underlying the penetrance of LHON remain poorly understood. Nuclear modifier genes have been long suspected to affect phenotype-severity, however, specific cellular pathways implicated in the disease penetrance have been only suggested recently. In recent years, autosomal recessive variants in nuclear genes involved in complex I function and metabolic pathways were recognised to cause a typical LHON phenotype. This was proposed as a new autosomal recessive disease mechanism for LHON (arLHON). The association between nuclear variants and the LHON phenotype makes the nuclear pathways disrupted in arLHON the strongest candidates to act as modifiers of mitochondrial LHON (mLHON). In this study we systematically investigated a large cohort of 23 symptomatic and 28 asymptomatic individuals carrying one of the three primary mitochondrial LHON variants. We identified several heterozygous pathogenic nuclear variants amongst the affected individuals that were consistently linked to metabolic and complex I related pathways, mirroring those disrupted in arLHON. Our findings are consistent with the presence of a second hit in specific biological pathways impairing ATP production. We propose that in addition to the primary mitochondrial variants, disruption in these nuclear-encoded pathways drives the clinical manifestation of LHON. Genes involved in the same pathways also emerge as exciting candidates for future association with arLHON. The present study deepens our understanding of LHON's pathophysiology and provides a new framework for identifying novel disease-modifying targets.

#5

A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.

Molecular genetics and genomics : MGG2026 Mar 21

Inherited ocular fundus diseases are the most common causes of blindness with high heterogeneity. We established a tiered strategy for the molecular diagnosis of unexplained vision loss patients. Patients were screened with ophthalmological examinations followed by a tiered genetic diagnosis, including mitochondrial genome sequencing, multigene panel and whole exome sequencing. A total of 146 individuals with unexplained vision loss were enrolled, including 103 individuals with abnormal pattern visual evoked potential and 43 individuals with abnormal optic coherence tomography. Based on our tiered strategy for molecular diagnosis, 33 cases were diagnosed with Leber's hereditary optic neuropathy, with common or very rare mitochondrial variants. Moreover, 22 cases with monogenic disorders were diagnosed with 15 novel and 16 reported mutations. Our study reveals the genetic etiology of unexplained vision loss and expands the genetic variation spectrum. The tiered cost-effective strategy for molecular diagnosis improves genetic detection rates and is expected to be applied to future clinical practice.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.356 artigos no totalmostrando 197

2026

Chronic Progressive External Ophthalmoplegia Associated With the m.14484T>C Leber Hereditary Optic Neuropathy Mutation.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.

Molecular genetics and genomics : MGG
2026

Integrated molecular and clinical profiling of primary mitochondrial oxidative phosphorylation disorders in an Indian cohort: Insights from genetics, neuroimaging, and machine learning.

Mitochondrion
2026

A Case Report of Late-Onset Leber's Hereditary Optic Neuropathy Diagnosed Following Vision Loss After Cataract Surgery.

Neuro-ophthalmology (Aeolus Press)
2026

Visual Loss from Leber's Optic Neuropathy Presenting in a 76-Year-Old Man with the 14484 Mutations.

Neuro-ophthalmology (Aeolus Press)
2026

Five-year post-onset visual acuity trajectories in Japanese Leber hereditary optic neuropathy: a longitudinal analysis by age, sex, and mtDNA mutation.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Leber Hereditary Optic Neuropathy Caused by the Rare MT-ND1 m.3394T>C Mutation: A Case With Favorable Visual Prognosis and a Literature Review.

Cureus
2026

A Heteroplasmic MT-CO2 m.8024G > A Variant Is Associated with Mitochondrial Bioenergetic Deficiency and Optic Atrophy.

Molecular neurobiology
2026

Mesenchymal stem cell mitochondrial transfer effectively protects Leber's Hereditary Optic Neuropathy (LHON) mutant cells from mitochondrial damage.

Acta histochemica
2026

Oxidative stress imbalance and cellular damage mediated by the ND4 G11778A mutation.

Scientific reports
2026

Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.

Science advances
2026

Diagnostic and Imaging Features of Leber Hereditary Optic Neuropathy: An Individual Participant Data Meta-Analysis.

AJNR. American journal of neuroradiology
2026

Optic neuropathy arising from the synergy between YARS2 and mitochondrial COX1 mutations.

Journal of genetics and genomics = Yi chuan xue bao
2026

Molecular Mechanism of Mitochondrial Complex I Disruption by m.14484T>C Underlying Leber Hereditary Optic Neuropathy.

bioRxiv : the preprint server for biology
2026

Pharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.

Investigative ophthalmology &amp; visual science
2025

Oxidative Stress and Inflammatory Biomarkers in Aqueous Humor and Blood of Patients with Leber's Hereditary Optic Neuropathy.

Antioxidants (Basel, Switzerland)
2026

Leber Hereditary Optic Neuropathy-Associated Novel Mutation in MT-RNR2 Gene: A Case Report.

Case reports in ophthalmology
2026

Difference in pupillary response to red and blue color stimuli between glaucoma and Leber hereditary optic neuropathy patients with comparable central visual dysfunction.

Documenta ophthalmologica. Advances in ophthalmology
2025

Amyotrophic Lateral Sclerosis With Concurrent LHON-associated m.14484T>C Mutation: A Case Report and Literature Review.

Revista de neurologia
2025

Comparison of thickness changes in retinal nerve fibre layer in Leber's hereditary optic neuropathy patients with 11778, 14484 and 3460 mutations.

Translational pediatrics
2026

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Maternal lineage diversity and health-related haplogroups in the Gilgiti and Kohistani populations of northern Pakistan.

BMC genomics
2025

Mitochondrial-Immune Overlap in Leber Hereditary Optic Neuropathy: A Case Report and Lessons Learned.

Reports (MDPI)
2025

Another One: A Novel Variant Associated With Leber Hereditary Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Differentiating Leber's Hereditary Optic Neuropathy from Optic Neuritis in a Clinical Setting.

Annals of Indian Academy of Neurology
2025

Optic Atrophy Predominant WFS1 Disorder-A Case-Control Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy.

Brain communications
2025

Mitochondria-targeted gene delivery using fluorinated lipid nanoparticles to alleviate Leber's hereditary optic neuropathy.

Nature communications
2025

Trans-generational maintenance of mitochondrial DNA integrity in oocytes during early folliculogenesis.

PLoS genetics
2026

Advanced therapies for inherited optic neuropathies.

Eye (London, England)
2025

Preclinical Assessment of Mitochondrial-Targeted ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.

Investigative ophthalmology &amp; visual science
2025

Metformin promotes mitochondrial integrity through AMPK-signaling in Leber's hereditary optic neuropathy.

FEBS open bio
2025

In vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON.

Nature communications
2025

[Pathogenic mechanisms of Leber hereditary optic neuropathy caused by m.3472T>C mutation].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2025

The Pedigree Study of Leber's Hereditary Optic Neuropathy in Korean Population.

Seminars in ophthalmology
2025

Recessive variants in mitochondrial Complex I nuclear subunits are an underrated cause of optic atrophy.

Brain : a journal of neurology
2025

From Castro to Quantum Mechanics: Marching Through Tunnels With Reactive Oxygen Species.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Super mitochondria-enriched extracellular vesicles enable enhanced mitochondria transfer.

Nature communications
2025

Navigating Health When Sudden Blindness Occurs: The Experience of Leber Hereditary Optic Neuropathy.

Creative nursing
2025

Development of Two In Vitro ND1-LHON Models for Evaluating Gene Therapy Efficacy.

Investigative ophthalmology &amp; visual science
2025

Chromatic pupil campimetry as objective diagnostic tool for progressive optic neuropathies.

Documenta ophthalmologica. Advances in ophthalmology
2025

Exploring rare mitochondrial DNA in Leber hereditary optic neuropathy.

Advances in ophthalmology practice and research
2025

Visual Recovery in Leber's Hereditary Optic Neuropathy Plus: A Case Report and Literature Insight.

Case reports in ophthalmology
2025

Efficacy and safety of intravitreal rAAV2-ND4 therapy for Leber's hereditary optic neuropathy.

Eye (London, England)
2025

Establishment of human Leber's hereditary optic neuropathy model using iPSC-derived retinal organoids.

Frontiers in cellular neuroscience
2025

First Case in Lithuania of an Autosomal Recessive Mutation in the DNAJC30 Gene as a Cause of Leber's Hereditary Optic Neuropathy.

Genes
2025

Clinical Features of Leber Hereditary Optic Neuropathy Carrying a Rare m.13051G>A Mitochondrial Mutation: A Case Report.

Korean journal of ophthalmology : KJO
2025

Age-Associated Differences in Optic Disc Findings of Leber's Hereditary Optic Neuropathy.

Neuro-ophthalmology (Aeolus Press)
2025

A Case of Late-Onset Leber's Hereditary Optic Neuropathy in Association with Heteroplasmic m.11778G>A/ND4 Mutation.

Neuro-ophthalmology (Aeolus Press)
2025

Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov.

Journal of multidisciplinary healthcare
2025

Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial.

Eye (London, England)
2025

Whole mitochondrial genome sequencing in individuals with Leber hereditary optic neuropathy negative for the common pathogenic mitochondrial DNA variants.

Frontiers in neurology
2025

Rasch analysis of the NEI-VFQ-25: vision-related quality of life in Leber hereditary optic neuropathy after lenadogene nolparvovec gene therapy.

BMJ open ophthalmology
2025

Outcomes of idebenone therapy for Leber hereditary optic neuropathy in a cohort of patients from Wales.

Eye (London, England)
2025

An Additional Case of Leber Hereditary Optic Neuropathy With G9804A Mutation.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Structural insights into DdCBE in action enable high-precision mitochondrial DNA editing.

Molecular cell
2025

Estradiol alleviates disease phenotypes caused by m.3635G > A mutation by activating mitochondrial biogenesis and PINK1-Parkin mediated mitophagy in iPSC-derived retinal pigment epithelium cells.

Cellular signalling
2025

MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber's hereditary optic neuropathy in healthy MtDNA mutations carriers.

Metabolomics : Official journal of the Metabolomic Society
2025

Quantitative assessment of retinal microvasculature using optical coherence tomography angiography and correlation with visual acuity in leber's hereditary optic neuropathy.

International ophthalmology
2025

Metformin may alter the course of Leber's hereditary optic neuropathy: a case report.

Frontiers in medicine
2025

Late-onset Leber's hereditary optic neuropathy and antiandrogens for prostate cancer: is there a causative link?

Frontiers in neurology
2025

Developing Intravenous Delivery of Water-Soluble Prodrugs of Idebenone for the Treatment of Acute Ischemic Stroke.

ACS chemical neuroscience
2025

Evaluation of Visual and Optical Coherence Tomography Outcomes in Patients with Leber's Hereditary Optic Neuropathy Treated with Idebenone.

Life (Basel, Switzerland)
2025

Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber's hereditary optic neuropathy patient-derived fibroblasts.

Human molecular genetics
2025

Anterograde degeneration along the visual pathway following optic nerve injury: a review.

Frontiers in neurology
2025

Infographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial).

Eye (London, England)
2025

In Vivo Reprogramming Dysfunctional Retinal Ganglion Cells and Visual-phototransduction via Wireless Charging Nanogold for Leber's Hereditary Optic Neuropathy.

Advanced materials (Deerfield Beach, Fla.)
2025

Initial Macular Ganglion Cell Changes During Conversion of Leber Hereditary Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Extraocular features of Leber hereditary optic neuropathy: A scoping review.

Journal of biological methods
2025

Technological advances in the diagnosis and management of inherited optic neuropathies.

Frontiers in neurology
2025

"Adrift From the World": Exploring the Lived Experiences of Individuals Affected by an Inherited Optic Neuropathy in the United Kingdom-A Qualitative Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2025

Leber Hereditary Optic Neuropathy and Epilepsy in a Mexican Patient.

Cureus
2025

Acute Bilateral Vision Loss in a Young Male: A Case of Leber's Hereditary Optic Neuropathy.

Cureus
2025

Uncovering the Characteristics of Pupil Cycle Time (PCT) in Neuropathies and Retinopathies.

Vision (Basel, Switzerland)
2025

Large language models in neuro-ophthalmology diseases: ChatGPT vs Bard vs Bing.

International journal of ophthalmology
2025

Infographic: landmark trials in neuro-ophthalmology - results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy.

Eye (London, England)
2025

Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.

Investigative ophthalmology &amp; visual science
2025

Leber's Hereditary Optic Neuropathy.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2025

Therapeutic benefit of idebenone in Leber hereditary optic neuropathy: a systematic review and meta-analysis.

Ophthalmic genetics
2025

The Role of Estrogen in Mitochondrial Disease.

Cellular and molecular neurobiology
2025

Leber's hereditary optic neuropathy-associated ND1 3733G>C mutation ameliorates the mitochondrial quality control and cellular homeostasis.

The Journal of biological chemistry
2026

Clinical Characteristics of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Carriers of a Leber Hereditary Optic Neuropathy Variant.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

Optic nerve MRI findings in Leber's hereditary optic neuropathy.

Japanese journal of ophthalmology
2025

Antioxidant therapy in inborn metabolic diseases.

Molecular genetics and metabolism
2025

Early-Onset Hearing Loss in Leber's Hereditary Optic Neuropathy: A Case Report.

Ear, nose, &amp; throat journal
2025

Nitric Oxide May Adversely Affect the Metabolism and Viability of Retinal Organoids Derived from Patients with Leber Hereditary Optic Neuropathy.

The American journal of pathology
2025

Exploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective.

International journal of molecular sciences
2025

The crossroads of Leber hereditary optic neuropathy and autosomal dominant optic Atrophy: Clinical profiles of patients with coexisting pathogenic genetic variants.

American journal of ophthalmology case reports
2025

Bezafibrate was unsuccessful to treat leber hereditary optic neuropathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

[Mechanism of BNIP3-mediated mitophagy in m.3635G>A related Leber hereditary optic neuropathy].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Modifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.

European journal of human genetics : EJHG
2025

SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.

The Journal of clinical investigation
2025

Recurrent Optic Neuritis as a Misleading Presentation of Leber Hereditary Optic Neuropathy: The Need for High Clinical Suspicion in Young Men.

Cureus
2025

Leber hereditary optic neuropathy: utilities and carer burden from British and Irish participants.

Orphanet journal of rare diseases
2025

Isolated and Syndromic Genetic Optic Neuropathies: A Review of Genetic and Phenotypic Heterogeneity.

International journal of molecular sciences
2025

Idebenone vs. rAAV2-ND4 gene therapy in the treatment of Leber's hereditary optic neuropathy: An indirect comparison meta-analysis.

Indian journal of ophthalmology
2025

Leber hereditary optic neuropathy with the homoplasmic m.14484 T > C mutation presenting initially with cerebellar ataxia.

Journal of neurology
2025

Leber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge.

Cureus
2025

Central Vestibular Syndrome in Leber Hereditary Optic Neuropathy "Plus".

Neuropediatrics
2025

Novel in vivo models of autosomal optic atrophy reveal conserved pathological changes in neuronal mitochondrial structure and function.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study.

Orphanet journal of rare diseases
2025

Alterations in ganglion cell and nerve fiber layer in Leber hereditary optic neuropathy across clinical stages.

BMC ophthalmology
2025

Adult-Onset Bilateral Optic Neuropathy in a Patient with Non-Familial Childhood-Onset Generalized Dystonia Associated with Mitochondrial DNA 14459G>A Mutation: A Case Report and Review of Literature.

Neuro-ophthalmology (Aeolus Press)
2025

DNAJC30 Mutation in a Patient with Coexisting Leber's Hereditary Optic Neuropathy and Multiple Sclerosis (Harding's Syndrome): A Case Report.

Case reports in ophthalmology
2025

Communicating Hope and Fact to Families With Leber Hereditary Optic Neuropathy.

Clinical &amp; experimental ophthalmology
2025

Mitochondrial DNA Pathogenic Variants in Ophthalmic Diseases: A Review.

Genes
2025

Early Macular Ganglion Cell Loss in Leber Hereditary Optic Neuropathy, an Optical Coherence Tomography Biomarker to Differentiate Optic Neuritis.

Journal of clinical medicine
2025

[Evaluation of retinal microvascular characteristics in Leber hereditary optic neuropathy based on optical coherence tomography angiography].

Zhonghua yi xue za zhi
2025

Leber hereditary optic neuropathy in a family with two primary pathogenic variants: Report of a pedigree and review of the literature.

Journal francais d'ophtalmologie
2025

Peripapillary hyperreflective ovoid mass-like structure (PHOMS) and optic disc drusen in pediatric pseudo-papilledema.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Remarkable visual improvement in Leber hereditary optic neuropathy.

Japanese journal of ophthalmology
2025

Leber's Hereditary Optic Neuropathy with Retinal Hemorrhage.

Neuro-ophthalmology (Aeolus Press)
2025

Leber's hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation.

Frontiers in neurology
2025

Vitamin A treatment restores vision failures arising from Leber's hereditary optic neuropathy-linked mtDNA mutation.

JCI insight
2025

Research progress on paternal mitochondrial inheritance: An overview.

Mitochondrion
2025

The rAAV2-ND1 gene therapy for Leber hereditary optic neuropathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2024

Leber Hereditary Optic Neuropathy "Plus" with the m.14487 T>C Mutation as the Causality of Hemidystonia: A Case Report.

Case reports in ophthalmology
2025

Leber's hereditary optic neuropathy - current status of idebenone and gene replacement therapies.

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V
2025

Frequency and Pattern of Gene Therapy Clinical Trials for Inherited Retinal Diseases.

Advances in experimental medicine and biology
2025

An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy.

Scientific reports
2025

Clinical spectrum, treatment and outcomes of the m.10197G>A mutation in MT-ND3: a case report, systematic review and meta-analysis.

Orphanet journal of rare diseases
2025

A Case of Leber's Hereditary Optic Neuropathy With Reversible Symmetric Lesions in the Substantia Nigra.

Cureus
2025

Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices.

Clinical &amp; experimental ophthalmology
2024

Central Serous Chorioretinopathy Associated with Corticosteroid Use in a Patient with Leber Hereditary Optic Neuropathy: A Case Report.

Medicina (Kaunas, Lithuania)
2025

Atypical Leber Hereditary Optic Neuropathy (LHON) Associated with a Novel MT-CYB:m.15309T>C(Ile188Thr) Variant.

Genes
2025

Precise modelling of mitochondrial diseases using optimized mitoBEs.

Nature
2024

A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.

Frontiers in medicine
2025

Family and genetic counseling in Leber hereditary optic neuropathy.

Ophthalmic genetics
2024

Nanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria.

Acta pharmaceutica Sinica. B
2024

Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Idebenone Protects Photoreceptors Impaired by Oxidative Phosphorylation Disorder in Retinal Detachment.

Investigative ophthalmology &amp; visual science
2024

Insights on the Genetic and Phenotypic Complexities of Optic Neuropathies.

Genes
2025

Visual Functions in Patients With Leber Hereditary Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Risk Factors Associated With Leber Hereditary Optic Neuropathy due to Rare Mutations in Mitochondrial DNA-Encoded Respiratory Complex I Subunits.

Clinical genetics
2025

Reprogramming patient-induced pluripotent stem cell-specific retinal organoids for deciphering epigenetic modifications of RNA methylation.

Journal of the Chinese Medical Association : JCMA
2025

Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities.

Current opinion in neurology
2025

Single-Eye Gene Therapy for Leber Hereditary Optic Neuropathy.

JAMA ophthalmology
2025

Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy.

JAMA ophthalmology
2024

Opa1 and MT-Nd6 mutations induce early mitochondrial changes in the retina and prelaminar optic nerve of hereditary optic neuropathy mouse models.

Brain communications
2024

LNC-ing Genetics in Mitochondrial Disease.

Non-coding RNA
2024

Efficacy of Intravitreal rAAV2-ND4 Injection in Treated Versus Fellow Eyes with Leber's Hereditary Optic Neuropathy: A Meta-Analysis.

Neuro-ophthalmology (Aeolus Press)
2024

Respiratory Chain Complex I Deficiency in Leber Hereditary Optic Neuropathy: Insights from Ophthalmologic and Molecular Investigations in Tunisia.

BMC genomics
2024

[Brain magnetic resonance imaging features in Leber's hereditary optic neuropathy].

Vestnik oftalmologii
2024

Optic Neuropathy AFG3L2 Related in a Patient Affected by Congenital Stationary Night Blindness.

Case reports in ophthalmological medicine
2024

Childhood Blindness: A Rare Case of Leber Hereditary Optic Neuropathy in a 16-Year-Old Egyptian Patient.

Cureus
2024

Leber Hereditary Optic Neuropathy With Significant Visual Recovery: An MT-ND6 Mutation in a Malay Patient.

Cureus
2025

Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.

Brain : a journal of neurology
2025

Leber hereditary optic neuropathy with disc haemorrhage.

Eye (London, England)
2024

Recent advances in neuro-ophthalmology.

Indian journal of ophthalmology
2025

Clinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes.

Brain : a journal of neurology
2025

Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy.

Survey of ophthalmology
2024

Hypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway.

Scientific reports
2025

Monoallelic de novo variants in DDX17 cause a neurodevelopmental disorder.

Brain : a journal of neurology
2025

An Unusual Presentation of Leber Hereditary Optic Neuropathy-Plus Case Caused by a Novel DNAJC30 Variant.

American journal of medical genetics. Part A
2024

Ganglion Cell Complex Thickness and Visual Function in Chronic Leber Hereditary Optic Neuropathy.

Investigative ophthalmology &amp; visual science
2024

Recognizing Leber's Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis.

Frontiers in neurology
2024

Preservation of Mitochondrial Function by SkQ1 in Skin Fibroblasts Derived from Patients with Leber's Hereditary Optic Neuropathy Is Associated with the PINK1/PRKN-Mediated Mitophagy.

Biomedicines
2024

Retinal damage promotes mitochondrial transfer in the visual system of a mouse model of Leber hereditary optic neuropathy.

Neurobiology of disease
2024

Primary mitochondrial diseases.

Handbook of clinical neurology
2024

A transmitochondrial sodium gradient controls membrane potential in mammalian mitochondria.

Cell
2024

Diagnostic dilemma: Leber's hereditary optic neuropathy in a 70-year-Old woman.

American journal of ophthalmology case reports
2024

Ocular genetics in the Japanese population.

Japanese journal of ophthalmology
2024

Mitochondrial tRNAGlu 14693A > G Mutation, an "Enhancer" to the Phenotypic Expression of Leber's Hereditary Optic Neuropathy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective.

Orphanet journal of rare diseases
2024

Defective post-transcriptional modification of tRNA disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.

The Journal of biological chemistry
2024

Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress.

International journal of molecular sciences
2024

Metabolic Deficits in the Retina of a Familial Dysautonomia Mouse Model.

Metabolites
2024

Clinical follow-up investigation on thickness changes in the peripapillary retinal nerve fibre layer of patients with Leber hereditary optic neuropathy.

BMC ophthalmology
2024

Dysregulation of mitochondria, apoptosis and mitophagy in Leber's hereditary optic neuropathy with MT-ND1 3635G>A mutation.

Gene
2024

MSC-mediated mitochondrial transfer restores mitochondrial DNA and function in neural progenitor cells of Leber's hereditary optic neuropathy.

Science China. Life sciences
2024

Inhibition of angiogenesis by the secretome from iPSC-derived retinal ganglion cells with Leber's hereditary optic neuropathy-like phenotypes.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2025

Endocrine Disorders in Children with Primary Mitochondrial Diseases: Single Center Experience.

Journal of clinical research in pediatric endocrinology
2024

A Comprehensive Review of Leber Hereditary Optic Neuropathy and Its Association with Multiple Sclerosis-Like Phenotypes Known as Harding's Disease.

Eye and brain
2025

Family Planning in Genetic Optic Atrophies in Israel, a Case Series and a Discussion of Ethical Considerations.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

Leber Hereditary Optic Neuropathy Case Report: Clinical Presentation and Treatment with Idebenone Reinforce the Evidence for m.3866T>C as a Causative Variant.

Case reports in ophthalmology
2023

Extranuclear DNA Variations in the Susceptibility of Glaucoma.

Middle East African journal of ophthalmology
2024

Extensive Optic Tracts Involvement in the Acute Phase of Leber Hereditary Optic Neuropathy.

Neurology
2024

A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathy.

Clinical case reports
2024

Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy.

Japanese journal of ophthalmology
2024

Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective.

Heliyon
2024

Gene therapy for Leber hereditary optic neuropathy.

Expert opinion on biological therapy
2025

Optic Nerve T2 Signal Intensity and Caliber Reflect Clinical Severity in Genetic Optic Atrophy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

A computational study to assess the pathogenicity of single or combinations of missense variants on respiratory complex I.

International journal of biological macromolecules
2024

Electrodiagnostic tests of the visual pathway and applications in neuro-ophthalmology.

Eye (London, England)
2024

Maculopapillary Bundle Degeneration in Optic Neuropathies.

Current neurology and neuroscience reports
2024

Prevalence of Leber hereditary optic neuropathy in the Community of Madrid (Spain), estimation with a capture-recapture method.

Orphanet journal of rare diseases
2024

Genetic susceptibility to optic neuropathy in patients with alcohol use disorder.

Journal of translational medicine
2024

Impaired mitochondrial morphological plasticity and failure of mitophagy associated with the G11778A mutation of LHON.

Biochemical and biophysical research communications
2024

Co-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to DNAJC30 mutations.

European journal of neurology
2024

Leber's hereditary optic neuropathy like disease in MT-ATP6 variant m.8969G>A.

American journal of ophthalmology case reports
2024

Deep Brain Stimulation for Medication Refractory Tremor in Leber Optic Neuropathy Plus Syndrome.

Cureus
2024

Novel Mutations in the ND5 Gene Associated With Leber Hereditary Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

Atypical Late-Onset Leber Hereditary Optic Neuropathy (LHON) Associated With T14484C Mutation.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

Autosomal recessive leber hereditary optic neuropathy in a choroideremia carrier. A case report.

European journal of ophthalmology
2024

Galactose-replacement unmasks the biochemical consequences of the G11778A mitochondrial DNA mutation of LHON in patient-derived fibroblasts.

Experimental cell research
2025

Preserved Ganglion Cell Analysis in a Case of Longstanding Leber Hereditary Optic Neuropathy: A Sign of Hibernating Neurons?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

[Leber's hereditary optic neuropathy].

Rinsho shinkeigaku = Clinical neurology
Ver todos os 1.356 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Neuropatia óptica hereditária.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Neuropatia óptica hereditária

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.
    Science advances· 2026· PMID 41706861mais citado
  2. Pharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41626869mais citado
  3. Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41483035mais citado
  4. Modifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.
    European journal of human genetics : EJHG· 2026· PMID 40346165mais citado
  5. A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.
    Molecular genetics and genomics : MGG· 2026· PMID 41863617mais citado
  6. Leber Hereditary Optic Neuropathy in the Elderly: A Case Report.
    Case Rep Ophthalmol· 2026· PMID 41938630recente
  7. Optimized ND4 allotopic expression for gene therapy of Leber's hereditary optic neuropathy.
    Front Bioeng Biotechnol· 2026· PMID 41938059recente
  8. Leber hereditary optic neuropathy triggered by the AstraZeneca coronavirus disease 2019 vaccination.
    Oman J Ophthalmol· 2026· PMID 41930030recente
  9. Impact of individualized colored spectacle filters on photophobia and visual comfort in central visual field defect patients: a one-year study.
    Sci Rep· 2026· PMID 41888298recente
  10. Chronic Progressive External Ophthalmoplegia Associated With the m.14484T>C Leber Hereditary Optic Neuropathy Mutation.
    J Neuroophthalmol· 2026· PMID 41870410recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98671(Orphanet)
  2. MONDO:0020249(MONDO)
  3. GARD:19540(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55789244(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Neuropatia óptica hereditária
Compêndio · Raras BR

Neuropatia óptica hereditária

ORPHA:98671 · MONDO:0020249
CID-11
Ensaios
10 ativos
Medicamentos
1 registrados
MedGen
UMLS
C3887709
Repurposing
1 candidato
idebenonecalcium channel modulator
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades